Drug Profile
BBI 4007
Latest Information Update: 16 Apr 1997
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Antiulcers; Bifidobacteria
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastric ulcer
Most Recent Events
- 16 Apr 1997 No-Development-Reported for Gastric ulcer in Japan (Unknown route)
- 23 Jan 1995 New profile
- 23 Jan 1995 Investigation in Gastric ulcer in Japan (Unknown route)